The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon

Thelma R. Cowley, Rodrigo Esteban González-Reyes, Jill C. Richardson, David Virley, Neil Upton, Marina A. Lynch

Resultado de la investigación: Contribución a RevistaArtículo

8 Citas (Scopus)

Resumen

A non-selective antihistamine, dimebon, has recently emerged as a potential treatment for Alzheimer's disease and Huntington's disease. Dimebon exerts several effects in addition to its anti-histaminergic effect, and of particular interest is its ability to enhance cognitive function in several models. The mechanism underlying this is unknown though it has been suggested that it may be associated with its anti-cholinergic action. Dimebon has also been reported to be neuroprotective, perhaps as a result of its ability to stabilize mitochondria. We considered that these effects might impact on the well-described age-related impairment in spatial learning and therefore examined the effect of repeated administration of dimebon on performance of young and aged animals in the Morris water maze. Whereas a clear age-related deficit was observed, dimebon failed to exert any effect on performance. Similarly, dimebon exerted no effect on the age-related increase in hippocampal expression of several markers of microglial and astroglial activation. We conclude that, despite its cognitive enhancing effects in some models, dimebon failed to modulate the deficit in spatial learning in aged rats and the evidence suggests that the drug does not possess anti-inflammatory properties.

Idioma originalEnglish (US)
Páginas (desde-hasta)1190-1195
Número de páginas6
PublicaciónNeurochemical Research
Volumen38
N.º6
DOI
EstadoPublished - jun 2013
Publicado de forma externa

Huella dactilar

Gliosis
Aptitude
Histamine Agents
Mitochondria
Histamine Antagonists
Huntington Disease
Cholinergic Antagonists
latrepirdine
Spatial Learning
Cognition
Rats
Alzheimer Disease
Animals
Anti-Inflammatory Agents
Chemical activation
Water
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Biochemistry

Citar esto

Cowley, Thelma R. ; González-Reyes, Rodrigo Esteban ; Richardson, Jill C. ; Virley, David ; Upton, Neil ; Lynch, Marina A. / The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon. En: Neurochemical Research. 2013 ; Vol. 38, N.º 6. pp. 1190-1195.
@article{6c31345ec12a4636a1f0346202e71be7,
title = "The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon",
abstract = "A non-selective antihistamine, dimebon, has recently emerged as a potential treatment for Alzheimer's disease and Huntington's disease. Dimebon exerts several effects in addition to its anti-histaminergic effect, and of particular interest is its ability to enhance cognitive function in several models. The mechanism underlying this is unknown though it has been suggested that it may be associated with its anti-cholinergic action. Dimebon has also been reported to be neuroprotective, perhaps as a result of its ability to stabilize mitochondria. We considered that these effects might impact on the well-described age-related impairment in spatial learning and therefore examined the effect of repeated administration of dimebon on performance of young and aged animals in the Morris water maze. Whereas a clear age-related deficit was observed, dimebon failed to exert any effect on performance. Similarly, dimebon exerted no effect on the age-related increase in hippocampal expression of several markers of microglial and astroglial activation. We conclude that, despite its cognitive enhancing effects in some models, dimebon failed to modulate the deficit in spatial learning in aged rats and the evidence suggests that the drug does not possess anti-inflammatory properties.",
author = "Cowley, {Thelma R.} and Gonz{\'a}lez-Reyes, {Rodrigo Esteban} and Richardson, {Jill C.} and David Virley and Neil Upton and Lynch, {Marina A.}",
year = "2013",
month = "6",
doi = "10.1007/s11064-012-0884-0",
language = "English (US)",
volume = "38",
pages = "1190--1195",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "6",

}

The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon. / Cowley, Thelma R.; González-Reyes, Rodrigo Esteban; Richardson, Jill C.; Virley, David; Upton, Neil; Lynch, Marina A.

En: Neurochemical Research, Vol. 38, N.º 6, 06.2013, p. 1190-1195.

Resultado de la investigación: Contribución a RevistaArtículo

TY - JOUR

T1 - The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon

AU - Cowley, Thelma R.

AU - González-Reyes, Rodrigo Esteban

AU - Richardson, Jill C.

AU - Virley, David

AU - Upton, Neil

AU - Lynch, Marina A.

PY - 2013/6

Y1 - 2013/6

N2 - A non-selective antihistamine, dimebon, has recently emerged as a potential treatment for Alzheimer's disease and Huntington's disease. Dimebon exerts several effects in addition to its anti-histaminergic effect, and of particular interest is its ability to enhance cognitive function in several models. The mechanism underlying this is unknown though it has been suggested that it may be associated with its anti-cholinergic action. Dimebon has also been reported to be neuroprotective, perhaps as a result of its ability to stabilize mitochondria. We considered that these effects might impact on the well-described age-related impairment in spatial learning and therefore examined the effect of repeated administration of dimebon on performance of young and aged animals in the Morris water maze. Whereas a clear age-related deficit was observed, dimebon failed to exert any effect on performance. Similarly, dimebon exerted no effect on the age-related increase in hippocampal expression of several markers of microglial and astroglial activation. We conclude that, despite its cognitive enhancing effects in some models, dimebon failed to modulate the deficit in spatial learning in aged rats and the evidence suggests that the drug does not possess anti-inflammatory properties.

AB - A non-selective antihistamine, dimebon, has recently emerged as a potential treatment for Alzheimer's disease and Huntington's disease. Dimebon exerts several effects in addition to its anti-histaminergic effect, and of particular interest is its ability to enhance cognitive function in several models. The mechanism underlying this is unknown though it has been suggested that it may be associated with its anti-cholinergic action. Dimebon has also been reported to be neuroprotective, perhaps as a result of its ability to stabilize mitochondria. We considered that these effects might impact on the well-described age-related impairment in spatial learning and therefore examined the effect of repeated administration of dimebon on performance of young and aged animals in the Morris water maze. Whereas a clear age-related deficit was observed, dimebon failed to exert any effect on performance. Similarly, dimebon exerted no effect on the age-related increase in hippocampal expression of several markers of microglial and astroglial activation. We conclude that, despite its cognitive enhancing effects in some models, dimebon failed to modulate the deficit in spatial learning in aged rats and the evidence suggests that the drug does not possess anti-inflammatory properties.

UR - http://www.scopus.com/inward/record.url?scp=84878018261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878018261&partnerID=8YFLogxK

U2 - 10.1007/s11064-012-0884-0

DO - 10.1007/s11064-012-0884-0

M3 - Article

C2 - 23011205

AN - SCOPUS:84878018261

VL - 38

SP - 1190

EP - 1195

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 6

ER -